BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
NCT04072042
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
Apatinib monotherapy
Sponsor
Ruijin Hospital